Resources by Therapeutic Area
Observational study of long- term persistent elevation of neurodegeneration markers after cardiac surgery
DiMeglio M, Furey W, Hajj J, Lindekens J, Patel S, Acker M, Bavaria J, . Szeto WY, Atluri P, Haber M, Diaz-Arrastia R & Laudanski K. Sci Rep. 2019 May 9;9(1):7177. DOI: 10.1038/s41598-019-42351-2.
Prospective Clinical Trial Measuring the Effects of Cardiopulmonary Bypass Under Mild Hypothermia on the Inflammatory Response and Regulation of Cold-Shock Protein RNA-Binding Motif 3.
Rosenthal LM, Tong G, Wowro S, Walker C, Pfitzer C, Bottcher W, Miera O, Berger F and Schmitt KRL. Ther Hypothermia Temp Manag. 2019 Apr 11 DOI: 10.1089/ther.2018.0038 ABSTRACT
Point-of-Care Compatibility of Ultra-Sensitive Detection Techniques for the Cardiac Biomarker Troponin I-Challenges and Potential Value
Regan B, O'Kennedy R and Collins D Biosensors (Basel). 2018 Nov 21;8(4) DOI: 10.3390/bios8040114 ABSTRACT
Speaker: Dan Sikkema, PhD, Vice President Biomarker Services, QuanterixModerator: Dr. Jayshan Carpen, Moderator, Nature Research
Relations between elevated circulating cardiac troponin I (cTnI) levels and adverse cardiac outcomes were established prior to the advent of methods to measure extremely low levels of cTnI. Recently developed ELISA assays/platforms with ultra-high sensitivity cTnI (u-hs-cTnI) allow accurate measurem…